相关实验视频

Updated: Jul 24, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

鼻癌的免疫疗法:目前的状况和前景 (综述)

Huageng Huang¹, Yuyi Yao¹, Xinyi Deng²

¹Department of Oncology, Sun Yat‑sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong 510060, P.R. China.

International journal of oncology

|July 7, 2023

概括

免疫疗法为复发性或转移性鼻癌 (NPC) 提供了一个有希望的新疗法,这种癌症与爱斯坦-巴尔病毒 (EBV) 有关. 本综述探讨了各种免疫治疗方法,包括免疫检查点抑制剂和疫苗,用于先进的NPC.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
病毒学病毒学

背景情况:

鼻癌 (NPC) 是一种表皮瘤,与爱斯坦-巴尔病毒 (EBV) 感染密切相关.
虽然早期的NPC通常可以通过放射治疗治愈,但超过70%的患者患有晚期或转移性疾病.
很大一部分晚期NPC患者因复发和转移 (R/M) 而经历治疗失败,常规疗法有效性有限,副作用严重.

研究的目的:

审查在NPC治疗中使用免疫疗法的理由.
总结NPC临床研究中各种免疫治疗方法的现状,进展和挑战.
为临床实践和NPC免疫疗法的未来研究提供见解.

主要方法:

对NPC免疫疗法临床研究和研究的文献综述.
分析不同的免疫治疗方式,包括免疫检查点抑制剂,疫苗,免疫调节剂,采用细胞转移和EBV特异性单克隆抗体.
在先进的NPC中综合了这些治疗方法的安全性和疗效的数据.

主要成果:

免疫疗法已成为R/M NPC的有希望的治疗方法,在临床研究中取得了相当大的进展.
目前正在研究各种免疫治疗策略,这些策略显示出比传统治疗更有潜在的益处.
在优化这些疗法以广泛临床应用方面仍然存在挑战.

结论:

免疫疗法在管理先进和R/M NPC方面取得了重大进展.
对这些不同的免疫治疗策略进行进一步的研究和临床调查至关重要.
这份全面的概述旨在为临床实践和NPC免疫治疗的未来研究方向提供见解.

关键词:

爱斯坦-巴尔病毒病毒.临床试验临床试验临床试验临床试验临床试验免疫疗法免疫疗法鼻癌 (nasopharyngeal carcinoma) 是一种发生在鼻的癌症.治疗治疗治疗治疗治疗治疗

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...